Benzamide

Benzamide

SCHEMBL1679183

NC(=O)c1ccccc1.c1ccncc1

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.73
CYP2C19 P33261 2/20 0.73
POLB P06746 1/20 0.73
PARP1 P09874 1/20 0.73
MAPT P10636 1/20 0.73
TSHR P16473 1/20 0.73
RECQL P46063 1/20 0.73
BLM P54132 1/20 0.73
PMP22 Q01453 1/20 0.73
HSD17B10 Q99714 1/20 0.73
TDP1 Q9NUW8 1/20 0.73
L3MBTL1 Q9Y468 1/20 0.73
F7 P08709 1/20 0.63
F3 P13726 1/20 0.63
SARM1 Q6SZW1 1/20 0.63
SIRT2 Q8IXJ6 1/20 0.63
SIRT6 Q8N6T7 1/20 0.63
SIRT1 Q96EB6 1/20 0.63
SIRT3 Q9NTG7 1/20 0.63
SIRT5 Q9NXA8 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31228697 0.98 CYP3A4 (0.70) CYP3A4CYP2C19POLBPARP1MAPT
Benzamide SCHEMBL27937969 0.94 CYP3A4 (0.64) CYP3A4CYP2C19POLBPARP1MAPT
Benzamide SCHEMBL1679005 0.93 CYP3A4 (0.76) CYP3A4CYP2C19POLBPARP1MAPT
Pyridine SCHEMBL11103170 0.91 CYP3A4 (0.58) CYP3A4CYP2C19POLBPARP1MAPT
Benzamide SCHEMBL28787993 0.91 CYP3A4 (0.73) CYP3A4CYP2C19POLBPARP1MAPT
Benzamide SCHEMBL27841146 0.89 CYP3A4 (0.70) CYP3A4CYP2C19POLBPARP1MAPT
Benzamide SCHEMBL28132124 0.85 PARP1 (0.89) CYP3A4CYP2C19POLBPARP1MAPT
Benzamide SCHEMBL3870712 0.85 PARP1 (0.89) CYP3A4CYP2C19POLBPARP1MAPT
Benzamide SCHEMBL8632915 0.85 PARP1 (0.89) CYP3A4CYP2C19POLBPARP1MAPT
Benzamide SCHEMBL6690447 0.85 PARP1 (1.00) CYP3A4CYP2C19POLBPARP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113735850-A Synthesis method of 1,2, 4-triazole compound 河南师范大学 2021-12-03 CN claimed
CN-106831285-A The method that acid amides, urea are converted into ester 湖北科技学院 2017-06-13 CN claimed
CN-104860308-B A kind of method that application combustion synthesis method prepares nitrogen-doped graphene 哈尔滨工业大学 2017-05-31 CN claimed
CN-101917856-A Combinations comprising a fungicidal strain and an active compound BASF SE 2010-12-15 CN claimed
CN-120157555-A Preparation method of primary amide compound 浙江工业大学 2025-06-17 CN disclosed
CN-113735850-A Synthesis method of 1,2, 4-triazole compound 河南师范大学 2021-12-03 CN disclosed
CN-113735850-A Synthesis method of 1,2, 4-triazole compound 河南师范大学 2021-12-03 CN disclosed
WO-2021018165-A1 PYRIDINE BENZAMIDE DERIVATIVE, PREPARATION METHOD FOR SAME, AND MEDICINAL APPLICATIONS THEREOF 江苏恒瑞医药股份有限公司 2021-02-04 WO disclosed
WO-2021018165-A1 PYRIDINE BENZAMIDE DERIVATIVE, PREPARATION METHOD FOR SAME, AND MEDICINAL APPLICATIONS THEREOF 江苏恒瑞医药股份有限公司 2021-02-04 WO disclosed
CN-107573950-B A kind of aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display element 中节能万润股份有限公司 2019-09-03 CN disclosed
CN-109593089-A The preparation of diaza spiro decane piperidine formyl amine compound and application 西南大学 2019-04-09 CN disclosed
CN-108367000-A THERAPEUTIC AGENT FOR BREAST CANCER 卫材R&D管理有限公司 2018-08-03 CN disclosed
WO-2002066413-A1 FLECAINIDE SYNTHESIS NARCHEM CORPORATION (US) 2002-08-29 WO disclosed
EP-0912516-A4 ANTICONVULSANT PYRIDINYL BENZAMIDE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2002-06-12 EP disclosed
EP-0912516-A1 ANTICONVULSANT PYRIDINYL BENZAMIDE DERIVATIVES Bristol-Myers Squibb Company (US) 1999-05-06 EP disclosed
US-5859033-A Anticonvulsant pyridinyl benzamide derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 1999-01-12 US disclosed
WO-1997043261-A1 ANTICONVULSANT PYRIDINYL BENZAMIDE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 1997-11-20 WO disclosed
US-5550122-A INHIBIT REVERSE TRANSCRIPTASE BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1996-08-27 US disclosed
EP-0415303-B1 Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1995-12-13 EP disclosed
EP-0415303-A2 Pyrido [2,3-b][1,5]benzoxazepin (and thiazepin)-5(6H)-ones and -thiones and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-03-06 EP disclosed